Next, we constructed EJ and T24 cells that overexpressed DEPDC1A, and cells in which ALPK2 was knocked down while DEPDC1A was overexpressed, and used these groups of cells to investigate the synergistic effects of DEPDC1A and ALPK2 on bladder cancer. This evidence concerns the gene ALPK2 and urinary bladder cancer.